JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Distribution of ABO blood groups and Rh factor in benign and malign thyroid nodules
Abstract
Aims: Many factors affect the diagnostic value of the fine-needle aspiration biopsy applied for these thyroid nodules. I aimed to investigate whether one of these factors would be ABO blood groups and Rh factor and examine the relationship of these factors with the Bethesda categorization. Additionally, I aimed to evaluate ABO blood groups and Rh factors in patients with thyroid cancer. Material and
Methods: This study was planned in a cross-sectional retrospective design. The data of the patients were obtained from the hospital data bank. In the analysis of 801 patients following the acceptance criteria, 412 patient data were obtained. Patients were divided into 4 (O, A, B, and AB groups) according to their blood groups and analyzed for nodules (solitary/ multinodular). Nodules were divided into malignant and benign, according to histopathological diagnosis, and all were analyzed.
Results: There was no difference in analyzing the demographic data according to the blood groups. The rates of the FNAB history were 51 (32.3%), 39 (24.2%), 14 (26.4%), and 13 (32.5%) in the same order of blood groups (p=0.393). In the analysis of the nodule type, multinodular did not differ from solitary nodules among the blood groups [O: 141 (89.2%); A:140(87%), B: 46(86.8%), and AB: 35(87.5%)]. Thyroid function status (euthyroid, hypothyroid, or hyperthyroid) was similar for all the blood groups (p=0.815). The O-group had 1 (0.6%) patient with Bethesda score-6, and the A-group had 2 (1.2%) patients with Bethesda score-6. For Bethesda score-5, per blood group had 2 patients. The histopathological distribution of malign nodules (p=0.782) is as follows: O-groups: 6 (33.3%) (Rh+:27%; Rh-:5,5%), A groups: 7(63,6%) (Rh+:54,5%; Rh-:0,9%), B groups: 2(20%)(Rh+:20%; Rh-:0%) and AB groups: 1(33%) (Rh+:33%) Rh-:0%).
Conclusion: Malign nodule rate was highest in the A-group and lowest in the B groups, although it did not differ in the overall analysis. No relationship was found between the Bethesda categorization of nodules, their sizes, type of nodules, type of thyroid cancer, and ABO blood groups.

Keywords : Thyroid biopsy, Bethesda score, ABO blood group, Rh factor, malign nodule, benign nodule

Download Article


1. Zamora EA, Khare S, Cassaro S. Thyroid Nodule. In: StatPearls.Treasure Island (FL): StatPearls Publishing; September 5, 2022.
2. Ageeli RS, Mossery RA, Othathi RJ, et al. The importance of thethyroid nodule location in determining the risk of malignancy: aretrospective study. Cureus 2022; 14: e29421.
3. Abolhasani Foroughi A, Mokhtari M, et al. Concordance betweenTIRADS and cytology in thyroid nodule. Iran J Otorhinolaryngol2022; 34: 295-302.
4. Yang H, Yan J. A systematic review of prognosis of ABO bloodgroup and rhesus factor on outcomes in patients with bladdercancer. Medicine (Baltimore) 2022; 101: e30893.
5. Wang J, García-Bailo B, Nielsen DE, El-Sohemy A. ABO genotype,'blood-type' diet and cardiometabolic risk factors. PLoS One2014; 9: e84749.
6. Liumbruno GM, Franchini M. Hemostasis, cancer, and ABOblood group: the most recent evidence of association. J ThrombThrombolysis 2014; 38: 160-6.
7. Kim DS, Scherer PE. Obesity, diabetes, and increased cancerprogression. Diabetes Metab J 2021; 45: 799-812.
8. Kremer Hovinga IC, Koopmans M, de Heer E, Bruijn JA, BajemaIM. Change in blood group in systemic lupus erythematosus.Lancet 2007; 369: 186-7.
9. Dağdeviren M, Ateş İ, Demir BF, Ergün E, Yıldız C, Altay M.Investigation of blood groups in benign thyroid diseases inTurkey. Endocr J 2019; 66: 1001-9.
10. Vierbuchen M, Larena A, Schröder S, et al. Blood groupantigen expression in medullary carcinoma of the thyroid. Animmunohistochemical study on the occurrence of type 1 chain-derived antigens. Virchows Arch B Cell Pathol Incl Mol Pathol1992; 62: 79-88.
11. Dammann M, Weber F. Personalized medicine: caught betweenhope, hype and the real world. Clinics (Sao Paulo) 2012; 67: 91-7.
12. Tam AA, Özdemir D, Fakı S, Bilginer MC, Ersoy R, Çakır B. ABOblood groups, Rh factor, and thyroid cancer risk: to 'B' or not to'B'. Endocr Res 2020; 45: 137-46.
13. Balázs C. Örökletes és környezeti tényezok szerepe autoimmunpajzsmirigybetegségekben [The role of hereditary andenvironmental factors in autoimmune thyroid diseases]. OrvHetil 2012; 153: 1013-22.
14. Yu J, Gao F, Klimberg VS, Margenthaler JA. ABO blood type/Rhfactor and the incidence and outcomes for patients with triple-negative breast cancer. Ann Surg Oncol 2012; 19: 3159-64.
15. Stakisaitis D, Jukneviciene M, Ulys A, et al. ABO blood grouppolymorphism has an impact on prostate, kidney and bladdercancer in association with longevity. Oncol Lett 2018; 16: 1321-31.
16. Burgos N, Ospina NS, Sipos JA. The future of thyroid nodule riskstratification. Endocrinol Metab Clin North Am 2022; 51: 305-21.
17. Vasan SK, Hwang J, Rostgaard K, et al. ABO blood group andrisk of cancer: A register-based cohort study of 1.6 million blooddonors. Cancer Epidemiol 2016; 44: 40-3.
18. Zivaljevic V, Slijepcevic N, Paunovic I, et al. Risk factors foranaplastic thyroid cancer. Int J Endocrinol 2014; 2014: 815070.
19. Sencan M, Celik C, Dogan E, Sevimligul G. Blood groupdistribution of donors and patients admitted to the Bloodand Transfusion Center of Cumhuriyet University Hospital.Cumhuriyet Med J 2015; 37: 23-9.
Article available in :
Volume 6, Issue 2, 2023
Page : 462-466
https://doi.org/10.32322/jhsm.1243805
Article Information
Received : 28 Oca 2023
Accepted : 20 Şub 2023
Published : 27 Mar 2023
Corresponding Author :

Muzaffer Serdar Deniz: Department of Endocrinology, Karabük University Training and Research Hospital, Faculty of Medicine, Karabük University, Karabük, Turkey

[email protected]
Citation : Deniz MS. Distribution of ABO blood groups and Rh factor in benign and malign thyroid nodules. J Health Sci Med 2023; 6(2): 462-466.

Read: 136
Cited: 0
Download : 135
_Footer